Role of the anaphylatoxin receptor C5aR2 in angiotensin II induced hypertension and hypertensive end organ damage L Dreher, M Bode, N Ehnert, C Meyer-Schwesinger, T Wiech, J Köhl, ... American Journal of Hypertension, hpae082, 2024 | | 2024 |
Targeting T cell plasticity in kidney and gut inflammation by pooled single-cell CRISPR screening LUB Enk, M Hellmig, K Riecken, C Kilian, P Datlinger, SL Jauch-Speer, ... Science Immunology 9 (96), eadd6774, 2024 | | 2024 |
AB1525 DARATUMUMAB FOR REFRACTORY SYSTEMIC RHEUMATIC DISEASES: A SINGLE CENTER EXPERIENCE MT Holzer, I Kötter, T Xiong, N Ruffer, FC Feindt, S Melderis, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 2133-2134, 2024 | | 2024 |
Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma R Drexler, R Khatri, U Schüller, A Eckhardt, A Ryba, T Sauvigny, ... Acta Neuropathologica 147 (1), 21, 2024 | | 2024 |
Autoantibodies Targeting Nephrin in Podocytopathies FE Hengel, S Dehde, M Lassé, G Zahner, L Seifert, A Schnarre, O Kretz, ... New England Journal of Medicine, 2024 | | 2024 |
Dual-Energy CT muscle fat fraction as a new imaging biomarker of body composition and survival predictor in critically ill patients J Erley, K Roedl, AK Ozga, G de Heer, N Schubert, J Breckow, ... European Radiology, 1-11, 2024 | | 2024 |
Immune profiling-based targeting of pathogenic T cells with ustekinumab in ANCA-associated glomerulonephritis J Engesser, R Khatri, DP Schaub, Y Zhao, HJ Paust, Z Sultana, N Asada, ... | | 2024 |
A prognostic neural epigenetic signature in high-grade glioma R Drexler, R Khatri, T Sauvigny, M Mohme, CL Maire, A Ryba, Y Zghaibeh, ... Nature Medicine, 1-14, 2024 | 1 | 2024 |
Acute kidney injury predicts mortality in very elderly critically-ill patients EA Schmidt, S De Rosa, J Müller, P Hüsing, R Daniels, P Theile, ... European Journal of Internal Medicine, 2024 | | 2024 |
DEFICIENCY OF THE COMPLEMENT RECEPTOR C5AR2 HAS NO EFFECT ON BLOOD PRESSURE AND END ORGAN DAMAGE IN ANGIOTENSIN II INDUCED HYPERTENSION L Dreher, M Bode, N Ehnert, GR Herrnstadt, C Meyer-schwesinger, J Köhl, ... Journal of Hypertension 42 (Suppl 1), e44, 2024 | | 2024 |
WCN24-220 Associations of biomarkers of podocyte injury with histopathologic lesions and foot process effacement in individuals with glomerular disease IM Schmidt, M Hassanein, A Verme, S Claudel, S Rosan, C Huynh, ... Kidney International Reports 9 (4), S107, 2024 | | 2024 |
Ibrutinib-associated focal segmental glomerulosclerosis and the impact of podocin mutations in chronic lymphocytic leukemia J Czogalla, S Schliffke, S Lu, M Schwerk, H Petereit, T Zhang, S Liu, ... Kidney International 105 (4), 877-881, 2024 | | 2024 |
An antigen-specific chimeric autoantibody receptor (CAAR) NK cell strategy for the elimination of anti-PLA2R1 and anti-THSD7A antibody-secreting cells L Seifert, K Riecken, G Zahner, J Hambach, J Hagenstein, G Dubberke, ... Kidney International 105 (4), 886-889, 2024 | 2 | 2024 |
Assessment and Risk Prediction of Chronic Kidney Disease and Kidney Fibrosis Using Non-Invasive Biomarkers H Rupprecht, L Catanese, K Amann, FE Hengel, TB Huber, A Latosinska, ... International Journal of Molecular Sciences 25 (7), 3678, 2024 | | 2024 |
Non-Invasive Biomarkers for Diagnosis, Risk Prediction, and Therapy Guidance of Glomerular Kidney Diseases: A Comprehensive Review L Catanese, H Rupprecht, TB Huber, MT Lindenmeyer, FE Hengel, ... International Journal of Molecular Sciences 25 (6), 3519, 2024 | | 2024 |
Metabolic communication by SGLT2 inhibition AM Billing, YC Kim, S Gullaksen, B Schrage, J Raabe, A Hutzfeldt, ... Circulation 149 (11), 860-884, 2024 | 16 | 2024 |
The 14th International Podocyte conference 2023: From podocyte biology to glomerular medicine S Koehler, F Hengel, B Dumoulin, L Damashek, LB Holzman, K Susztak, ... Kidney International, 2024 | | 2024 |
Urinary peptidomic liquid biopsy for non-invasive differential diagnosis of chronic kidney disease E Mavrogeorgis, T He, H Mischak, A Latosinska, A Vlahou, JP Schanstra, ... Nephrology Dialysis Transplantation 39 (3), 453-462, 2024 | 6 | 2024 |
Daratumumab as rescue therapy in life-threatening granulomatosis with polyangiitis M Krusche, T Oqueka, D Wichmann, S Kluge, TB Huber, I Kötter, ... Rheumatology 63 (3), e94-e95, 2024 | 3 | 2024 |
Cisplatin Nephrotoxicity Is Critically Mediated by the Availability of BECLIN1 T Bork, C Hernando-Erhard, W Liang, Z Tian, K Yamahara, TB Huber International Journal of Molecular Sciences 25 (5), 2560, 2024 | | 2024 |